Cite
Development and validation of nomograms for predicting survival probability of patients with advanced adenocarcinoma in different EGFR mutation status.
MLA
Chen, Hsi-Chieh, et al. “Development and Validation of Nomograms for Predicting Survival Probability of Patients with Advanced Adenocarcinoma in Different EGFR Mutation Status.” PLoS ONE, vol. 14, no. 8, Aug. 2019, pp. 1–16. EBSCOhost, https://doi.org/10.1371/journal.pone.0220730.
APA
Chen, H.-C., Tan, E. C.-H., Liao, C.-H., Lin, Z.-Z., & Yang, M.-C. (2019). Development and validation of nomograms for predicting survival probability of patients with advanced adenocarcinoma in different EGFR mutation status. PLoS ONE, 14(8), 1–16. https://doi.org/10.1371/journal.pone.0220730
Chicago
Chen, Hsi-Chieh, Elise Chia-Hui Tan, Chih-Hsien Liao, Zhong-Zhe Lin, and Ming-Chin Yang. 2019. “Development and Validation of Nomograms for Predicting Survival Probability of Patients with Advanced Adenocarcinoma in Different EGFR Mutation Status.” PLoS ONE 14 (8): 1–16. doi:10.1371/journal.pone.0220730.